Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-24

Clinical Trial Update: Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether injections of buprenorphine can block opioid effects in individuals with opioid use disorder; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-04-24